Resident mast cells are the main initiators of anaphylactic leukotriene production in the liver

During anaphylaxis the sensitized liver can have substantial capacity for leukotriene production. However, the intrahepatic cellular source for these potent eicosanoid mediators has been unclear so far. We therefore analyzed the appropriate role of resident liver cells in organ‐specific generation of leukotrienes by immunohistochemical localization of 5‐lipoxygenase, by measurement of cysteinyl leukotriene production in animals or isolated livers and by histochemical monitoring of mast cells in rat, guinea pig and mouse livers, respectively. During anaphylaxis in vivo, these species all generated large amounts of leukotrienes. Immunohistochemistry with rat liver demonstrated resident mast cells as the predominant cell type in liver containing 5‐lipoxygenase. Rat and guinea pig livers contained numerous mast cells and produced substantial amounts of leukotrienes on antigen challenge; in contrast, mouse livers neither showed detectable mast cells nor generated leukotrienes when stimulated analogously. Infusion of histamine or serotonin (1 μmol/L each) or of the degranulating substance P (8 μmo/L) did not elicit leukotriene generation in rat livers. Furthermore, substantial degranulation of liver mast cells by compound 48/80 (0.5 mg/kg body mass) was paralleled by only modest leukotriene formation (63 ± 10 pmol in bile/kg body mass/30 min). These results indicate that during anaphylaxis mast cells are the main intrahepatic cells initiating leukotriene production and that such leukotriene generation is likely to be independent of mast cell degranulation or the release of histamine or serotonin.

[1]  W. Hagmann,et al.  The sensitized liver represents a rich source of endogenous leukotrienes , 1991, Hepatology.

[2]  E. Vignon,et al.  Serotonin‐stimulated phospholipase A2 and collagenase activation in chondrocytes from human osteoarthritic articular cartilage , 1991, FEBS letters.

[3]  T. Ishikawa,et al.  ATP-dependent primary active transport of cysteinyl leukotrienes across liver canalicular membrane. Role of the ATP-dependent transport system for glutathione S-conjugates. , 1990, The Journal of biological chemistry.

[4]  R. Murphy,et al.  Metabolism of leukotriene B4 in isolated rat hepatocytes. Involvement of 2,4-dienoyl-coenzyme A reductase in leukotriene B4 metabolism. , 1990, The Journal of biological chemistry.

[5]  Robert A. Lewis,et al.  Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. , 1990, The New England journal of medicine.

[6]  Y. Seyama,et al.  Immunological quantitation and immunohistochemical localization of leukotriene A4 hydrolase in guinea pig tissues. , 1990, The Journal of biological chemistry.

[7]  W. Hagmann,et al.  Hepatic uptake and metabolic disposition of leukotriene B4 in rats. , 1990, The Biochemical journal.

[8]  P. Piper,et al.  Pharmacological profile of leukotrienes E4, N-acetyl E4 and of four of their novel omega- and beta-oxidative metabolites in airways of guinea-pig and man in vitro. , 1989, British journal of pharmacology.

[9]  A. Guhlmann,et al.  Prevention of endogenous leukotriene production during anaphylaxis in the guinea pig by an inhibitor of leukotriene biosynthesis (MK-886) but not by dexamethasone , 1989, The Journal of experimental medicine.

[10]  M. Olson,et al.  Platelet-activating factor-stimulated hepatic glycogenolysis is not mediated through cyclooxygenase-derived metabolites of arachidonic acid. , 1989, Journal of Biological Chemistry.

[11]  W. Hagmann,et al.  Uptake, production and metabolism of cysteinyl leukotrienes in the isolated perfused rat liver. Inhibition of leukotriene uptake by cyclosporine. , 1989, Biochemical Journal.

[12]  C. Robinson,et al.  Differential release of histamine and eicosanoids from human skin mast cells activated by IgE‐dependent and non‐immunological stimuli , 1989, British journal of pharmacology.

[13]  M. Chan-yeung,et al.  Mast cell mediators stimulate synthesis of arachidonic acid metabolites in macrophages. , 1989, Journal of immunology.

[14]  D. Häussinger,et al.  Metabolism of cysteinyl leukotrienes in non-recirculating rat liver perfusion. Hepatocyte heterogeneity in uptake and biliary excretion. , 1989, European journal of biochemistry.

[15]  B. Greenwood,et al.  The immunocytochemical preservation of IgE and mast cells of the rat. , 1989, Journal of immunological methods.

[16]  S. Chock,et al.  Synthesis of prostaglandins and eicosanoids by the mast cell secretory granule. , 1988, Biochemical and biophysical research communications.

[17]  J. Warner,et al.  Effects of a specific inhibitor of the 5-lipoxygenase pathway on mediator release from human basophils and mast cells. , 1988, The Journal of pharmacology and experimental therapeutics.

[18]  S. Seki,et al.  Release of peptide leukotrienes from rat Kupffer cells. , 1988, Biochemical and biophysical research communications.

[19]  K. Jungermann,et al.  Leukotrienes increase glucose and lactate output and decrease flow in perfused rat liver. , 1988, Biochemical and biophysical research communications.

[20]  R. Murphy,et al.  Metabolism of leukotriene E4 in isolated rat hepatocytes. Identification of beta-oxidation products of sulfidopeptide leukotrienes. , 1988, The Journal of biological chemistry.

[21]  G. Feuerstein,et al.  N-acetyl-leukotriene E4 is a potent constrictor of rat mesenteric vessels. , 1988, European Journal of Pharmacology.

[22]  D. Keppler,et al.  w-oxidation products of leukotriene E4 in bile and urine of the monkey. , 1987, Biochemical and biophysical research communications.

[23]  S. Dahlén,et al.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. , 1987, Science.

[24]  D. Keppler,et al.  Leukotrienes as mediators in frog virus 3‐induced hepatitis in rats , 1987, Hepatology.

[25]  S. Yamamoto,et al.  Arachidonate 5-lipoxygenase of porcine leukocytes studied by enzyme immunoassay using monoclonal antibodies. , 1987, The Journal of biological chemistry.

[26]  D. Carson,et al.  Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. , 1987, Science.

[27]  P. Cannon,et al.  Endothelial cell leukotriene C4 synthesis results from intercellular transfer of leukotriene A4 synthesized by polymorphonuclear leukocytes. , 1986, The Journal of biological chemistry.

[28]  R. Bell,et al.  Contribution of macrophages to immediate hypersensitivity reaction. , 1986, Journal of immunology.

[29]  R. Murphy,et al.  Metabolism of leukotriene B4 in isolated rat hepatocytes. Identification of a novel 18-carboxy-19,20-dinor leukotriene B4 metabolite. , 1986, The Journal of biological chemistry.

[30]  K. Bernström,et al.  Metabolism of leukotriene E4 by rat tissues: formation of N-acetyl leukotriene E4. , 1986, Archives of biochemistry and biophysics.

[31]  D. Keppler,et al.  Identification of the major endogenous leukotriene metabolite in the bile of rats as N-acetyl leukotriene E4. , 1986, Prostaglandins.

[32]  D. Keppler,et al.  Leukotrienes as mediators in tissue trauma. , 1985, Science.

[33]  R. Clancy,et al.  Leukotriene C4 production by murine mast cells: evidence of a role for extracellular leukotriene A4. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Keppler,et al.  The relation of leukotrienes to liver injury , 1985, Hepatology.

[35]  J. Torchia,et al.  Catabolism of leukotriene A4 into B4, C4, and D4 by rat liver subcellular fractions. , 1985, Biochimica et biophysica acta.

[36]  O. Rådmark,et al.  Leukotriene A4-hydrolase activity in guinea pig and human liver. , 1985, Biochimica et biophysica acta.

[37]  S. Peters,et al.  Isolation and characterization of human intestinal mucosal mast cells. , 1985, Journal of immunology.

[38]  G. Feuerstein Autonomic pharmacology of leukotrienes. , 1985, Journal of autonomic pharmacology.

[39]  K. Decker Eicosanoids, Signal Molecules of Liver Cells , 1985, Seminars in liver disease.

[40]  M. Ui,et al.  Simultaneous inhibitions of inositol phospholipid breakdown, arachidonic acid release, and histamine secretion in mast cells by islet-activating protein, pertussis toxin. A possible involvement of the toxin-specific substrate in the Ca2+-mobilizing receptor-mediated biosignaling system. , 1985, The Journal of biological chemistry.

[41]  D. Keppler,et al.  Production of peptide leukotrienes in endotoxin shock , 1985, FEBS letters.

[42]  E. Goetzl,et al.  IgE-dependent and ionophore-induced generation of leukotrienes by dog mastocytoma cells. , 1983, Journal of immunology.

[43]  E. Corey,et al.  IgE-mediated release of leukotriene C4, chondroitin sulfate E proteoglycan, beta-hexosaminidase, and histamine from cultured bone marrow-derived mouse mast cells , 1983, The Journal of experimental medicine.

[44]  S. Peters,et al.  Generation of leukotrienes by purified human lung mast cells. , 1982, The Journal of clinical investigation.

[45]  L. Appelgren,et al.  Distribution and metabolism of 3H-labeled leukotriene C3 in the mouse. , 1982, The Journal of biological chemistry.

[46]  J. Flynn,et al.  Phospholipase A2 stimulated release of prostanoids from the isolated, perfused rabbit liver: implications in regional cellular injury. , 1981, Canadian journal of physiology and pharmacology.

[47]  R. McCuskey,et al.  Characterization of intensely fluorescent cells in the liver of the rat I. Histochemistry and 48/80‐induced degranulation , 1980, The Anatomical record.

[48]  M. Kaliner,et al.  The effects of the immunologic release of histamine upon human lung cyclic nucleotide levels and prostaglandin generation. , 1978, The Journal of clinical investigation.